Archer Daniels Midland Co. will expand NovaLipid(TM) production by adding capacity at its Mankato, Minn., enzyme interesterification facility. NovaLipid(TM) products are the company's line of zero/low trans-fat oils and margarines. Construction is scheduled to be completed late in 2005. This is the second expansion to the NovaLipid line. Last year, the company had announced that it was expanding its production at its Quincy, Ill., facility to help satisfy the food industry's demands as it moves forward to meet the Jan. 1, 2006, FDA labeling requirement.

"ADM is using its expertise to help food manufacturers meet consumers' demands for variety, taste and health," stated Paul B. Mulhollem, ADM president and chief operating officer. "The NovaLipid portfolio includes naturally stable oils, tropical oils, blended oils and enzyme interesterified shortenings and margarines to provide alternatives in various food applications including baking, confectionery, snack, frying and cereal products."



Source: Company Release